![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, July 07, 2012 2:08:53 PM
The scientist is Dr. Malcolm Fraser, and I think it is highly inappropriate to assume something about Dr. Fraser, unless this is a quote from him.
In the post you responded to Bob did not say "the scientist" he said "Dr. Malcolm Frazier (sic)"
Are you seriously basing your argument on the misspelling of a name???
In any case, Bob is Not making an unwarranted assumption.
Dr Fraser has been quoted many times as giving credit to KBLB for bringing him together with the other researchers to make this happen.
Dr Fraser has spent many years of his career working on the tools used to produce the chimeric transgenic silkworms and working on the creation of those worms.
Dr. Fraser's work has been supported by KBLB and his university is a stockholder in KBLB and will derive royalties from the sales of Monster Silk(TM).
While not absolutely proven, it is better than 90% certain that Dr. Fraser has been directly paid in KBLB shares for consulting work done for KBLB and that he still owns those shares and therefore has multiple financial interests in KBLB.
Dr. Kim Thompson (no one ever gives Him the respect of his JD or LLD at least) has stated that Dr. Fraser is an integral part of KBLB's team, and Fraser himself has said the same.
I have not noticed many here limiting themselves to direct quotes while talking about Kim T., Ben H., or any of the other names associated with KBLB so I find it Odd that you would expect Bob A. to so limit himself!
Mike L.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM